Elevated ALT activity is associated with a loss of the functional integrity of the cell membrane in the liver.62 Meanwhile, elevated hepatic ALP levels indicate cholestasis (failure of bile flow) rather than simple damage to liver cells.63 Therefore, these findings suggest that SynacinnTM might possess a hepatoprotective effect through protection against hepatocellular injury and cholestasis. Here, GPT is linked to cholestasis.